SCHEMBL9192600

SCHEMBL9192600

CC(C)CC(c1ccc(N)c([N+](=O)[O-])c1)n1ccnc1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CYP17A1 P05093 7/20 0.52
▸ CYP19A1 P11511 2/20 0.47
▸ ADRB2 P07550 1/20 0.43
▸ TSHR P16473 1/20 0.42
▸ CYP3A4 P08684 2/20 0.39
▸ CYP26A1 O43174 2/20 0.39
▸ CYP24A1 Q07973 1/20 0.38
▸ TDP1 Q9NUW8 3/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9194817 0.88 CYP17A1 (0.50) CYP17A1CYP19A1ADRB2TSHRCYP3A4
SCHEMBL9198545 0.86 CYP17A1 (0.52) CYP17A1CYP19A1ADRB2TSHRCYP24A1
SCHEMBL9663529 0.83 CYP17A1 (0.61) CYP17A1CYP19A1CYP3A4
SCHEMBL9190551 0.82 CYP19A1 (0.50) CYP17A1CYP19A1ADRB2TSHRCYP3A4
SCHEMBL9191682 0.77 CYP19A1 (0.62) CYP17A1CYP19A1CYP3A4CYP26A1TDP1
SCHEMBL12049974 0.76 CYP19A1 (0.50) CYP17A1CYP19A1CYP24A1
SCHEMBL10477336 0.76 CYP19A1 (0.61) CYP17A1CYP19A1CYP3A4TDP1MEN1
SCHEMBL12311722 0.76 CYP17A1 (0.51) CYP17A1CYP19A1CYP24A1ALDH1A1
SCHEMBL9235863 0.73 CYP19A1 (0.55) CYP17A1CYP19A1CYP3A4CYP26A1CYP24A1
SCHEMBL9193954 0.73 CYP19A1 (0.50) CYP17A1CYP19A1ADRB2TSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0371564-B1 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-07-12 — — EP disclosed
US-5151421-A Compounds for inhibition of metabolism of retinoids, for treatment for proliferation of epithelial cells and keratin disorders JANSSEN PHARMACEUTICA N.V. (BE) 1992-09-29 — — US disclosed
US-5028606-A Retinoid metabolism inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1991-07-02 — — US disclosed
EP-0371564-A2 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1990-06-06 — — EP disclosed
Send feedback